Followers | 251 |
Posts | 50315 |
Boards Moderated | 41 |
Alias Born | 08/29/2007 |
Sunday, March 31, 2024 12:56:17 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent SLN News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/17/2024 09:04:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/16/2024 06:21:17 PM
- Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress • Business Wire • 05/16/2024 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/14/2024 08:27:29 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 05/08/2024 09:14:57 PM
- Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference • Business Wire • 04/30/2024 12:30:00 PM
- Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors • Business Wire • 04/29/2024 12:30:00 PM
- Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a) • Business Wire • 04/08/2024 03:48:00 PM
- Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights • Business Wire • 03/13/2024 11:05:00 AM
- Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb • IH Market News • 03/13/2024 11:03:39 AM
- Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a) • Business Wire • 03/13/2024 11:00:00 AM
- Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024 • Business Wire • 02/28/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2024 01:12:00 PM
- Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial • Business Wire • 02/23/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:54:29 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:55:13 PM
- Silence Therapeutics Announces Oversubscribed $120 Million Private Placement • Business Wire • 02/05/2024 01:00:00 PM
- Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference • Business Wire • 01/31/2024 12:00:00 PM
- Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments • Business Wire • 12/01/2023 12:00:00 PM
- Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 12:00:00 PM
- Silence Therapeutics to Present at Jefferies London Healthcare Conference • Business Wire • 11/08/2023 12:00:00 PM
- Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease • Business Wire • 11/01/2023 11:00:00 AM
- Silence Therapeutics to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference • Business Wire • 09/26/2023 11:00:00 AM
- Silence Therapeutics to Participate in September Investor Conferences • Business Wire • 09/06/2023 11:00:00 AM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 08/29/2023 08:01:49 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM